Hepatoblastoma, the most common liver tumor in children and exhibited the lowest
mutational burden among solid cancers, pointing to chromosomal and epigenetic changes …

Hepatoblastoma stands as the most prevalent liver cancer in the pediatric population.
Characterized by a low mutational burden, chromosomal and epigenetic alterations are key …

Hepatoblastoma (HB) is an uncommon malignant liver cancer primarily affecting infants and
children, characterized by the presence of tissue that resembling fetal hepatocytes, mature …

Background & Aims Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the
predominant pediatric liver cancer, with limited therapeutic options for patients with …

Although hepatoblastoma is the most common pediatric liver cancer, its genetic
heterogeneity and therapeutic targets are not well elucidated. Therefore, we conducted a …

Hepatoblastoma (HB) is one of the most common hepatic malignancies in the pediatric
population. HB are composed of a variety of tumors, which derived from different origins and …

Background Hepatoblastoma is the most frequent pediatric liver cancer. The current
treatments lead to 80% of survival rate at 5 years. In this study, we evaluated the clinical …

Background & Aims Hepatoblastoma (HB) is the most common childhood liver cancer and
occasionally presents with histological and clinical features reminiscent of hepatocellular …

A deeper understanding of the genetic and molecular basis of hepatoblastoma (HB) has
fueled the hope to help in identifying genes and signaling pathways that are amenable to …

Hepatoblastoma is the most common hepatic malignancy during childhood. However, little is
still known about the molecular mechanisms that govern the development of this disease …